Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943276 · ClinicalTrials.gov registry record · NA
A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04943276: Completed NA study, sponsored by Stanford University.
NCT04943276 is a NA study that has completed, run by Stanford University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04943276, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will include temperature-related symptoms and temperature- related quality of life in individuals with POTS and impaired thermoregulation.
Interventions
- DEVICE Embr Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-02-27 |
| Est. Completion | 2023-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04943276
The ClinicalTrials.gov registry entry for NCT04943276 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Embr Device is the first listed.
NCT04943276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04943276 about?
NCT04943276 is a clinical study titled "A Novel Noninvasive Thermoregulatory Device for Postural Tachycardia Syndrome". The investigators hope to learn the feasibility and preliminary efficacy of the Embr device for improving thermal comfort in individuals with POTS and impaired thermoregulation. Feasibility will be assessed via usage of the Embr device and participant feedback. Preliminary efficacy measures will inc...
What is the current status of trial NCT04943276?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-02-27. Estimated completion is 2023-11-03.
What interventions are being tested in trial NCT04943276?
The interventions under investigation include: Embr Device (DEVICE).
Who is sponsoring clinical trial NCT04943276?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.